SI1708686T1 - Generally linear effervescent oral fentanyl dosage form and methods of administering - Google Patents
Generally linear effervescent oral fentanyl dosage form and methods of administeringInfo
- Publication number
- SI1708686T1 SI1708686T1 SI200431667T SI200431667T SI1708686T1 SI 1708686 T1 SI1708686 T1 SI 1708686T1 SI 200431667 T SI200431667 T SI 200431667T SI 200431667 T SI200431667 T SI 200431667T SI 1708686 T1 SI1708686 T1 SI 1708686T1
- Authority
- SI
- Slovenia
- Prior art keywords
- administering
- methods
- dosage form
- generally linear
- effervescent oral
- Prior art date
Links
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53361903P | 2003-12-31 | 2003-12-31 | |
US61566504P | 2004-10-04 | 2004-10-04 | |
EP04815716A EP1708686B1 (en) | 2003-12-31 | 2004-12-30 | Generally linear effervescent oral fentanyl dosage form and methods of administering |
PCT/US2004/043703 WO2005065319A2 (en) | 2003-12-31 | 2004-12-30 | Generally linear effervescent oral fentanyl dosage form and methods of administering |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1708686T1 true SI1708686T1 (en) | 2011-07-29 |
Family
ID=37657494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200431667T SI1708686T1 (en) | 2003-12-31 | 2004-12-30 | Generally linear effervescent oral fentanyl dosage form and methods of administering |
Country Status (5)
Country | Link |
---|---|
CN (2) | CN1901890B (en) |
ES (2) | ES2359979T3 (en) |
SI (1) | SI1708686T1 (en) |
UA (1) | UA91824C2 (en) |
ZA (1) | ZA200606172B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ612686A (en) * | 2010-12-16 | 2015-11-27 | Cynapsus Therapeutics Inc | Sublingual films |
CN109200025A (en) * | 2017-06-29 | 2019-01-15 | 哈尔滨莱博通药业有限公司 | A kind of asenapine maleate sublingual tablet |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6200604B1 (en) * | 1998-03-27 | 2001-03-13 | Cima Labs Inc. | Sublingual buccal effervescent |
-
2004
- 2004-12-30 UA UAA200608527A patent/UA91824C2/en unknown
- 2004-12-30 ES ES04815716T patent/ES2359979T3/en active Active
- 2004-12-30 CN CN2004800394845A patent/CN1901890B/en active Active
- 2004-12-30 SI SI200431667T patent/SI1708686T1/en unknown
- 2004-12-30 ES ES04815715T patent/ES2360114T3/en active Active
- 2004-12-30 CN CN2004800394883A patent/CN1901891B/en active Active
-
2006
- 2006-07-26 ZA ZA200606172A patent/ZA200606172B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1901891B (en) | 2011-07-13 |
CN1901890B (en) | 2012-03-14 |
ZA200606172B (en) | 2007-11-28 |
ES2360114T3 (en) | 2011-06-01 |
UA91824C2 (en) | 2010-09-10 |
ES2359979T3 (en) | 2011-05-30 |
CN1901890A (en) | 2007-01-24 |
CN1901891A (en) | 2007-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1615623A4 (en) | Abuse-resistant oral dosage forms and method of use thereof | |
EP1708686A4 (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering | |
IL166489A (en) | Two-layerd oral dosage form for once-a-day administration of paliperidone and uses thereof | |
HK1088543A1 (en) | Pharmaceutical compositions and dosage forms of thalidomide | |
EP1365747A4 (en) | Oral peptide pharmaceutical dosage form and method of production | |
HUP0303800A3 (en) | Pharmaceuticals and dosage forms of epothilones for oral administration | |
EP1469838A4 (en) | Manufacture of oral dosage forms delivering both immediate release and sustained release drugs | |
HK1107041A1 (en) | Oral compositions containing extracts of rosmarinus and related methods | |
HK1134023A1 (en) | Oral and personal care compositions and methods | |
HK1092061A1 (en) | Periodontal disease therapeutic and/or preventive composition | |
HK1082677A1 (en) | Androgen pharmaceutical composition and use for manufacture of medicament | |
ITTO20040621A1 (en) | Immunogen SYNTHETIC FOR THERAPY AND PROPHYLAXIS of misusing drugs and substances PSYCHOACTIVE | |
HK1066459A1 (en) | Pharmaceutical dosage form and method of making | |
IL166337A0 (en) | Oral administration of calctionin | |
IL162937A0 (en) | Pravastatin pharmaceutical formulations and methods of their use | |
HK1100352A1 (en) | Solid medicament of oral administration and preparation thereof | |
IL175746A0 (en) | Oral formulations of desoxypeganine and uses thereof | |
ZA200705093B (en) | Oral compositions containing extracts of rosmarinus and related methods | |
TW200611697A (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering | |
EP1670755A4 (en) | Pyrovalerone analogs and therapeutic uses thereof | |
ZA200606172B (en) | Generally linear effervescent oral fentanyl dosage form and methods of adminstering | |
HUP0402326A3 (en) | Pharmaceutical composition for prevention of addiction in pain management | |
IL162716A0 (en) | Oral pharmaceutical compositions for soft capsulescontaining vinorelbine and method of treatment | |
EP1666046A4 (en) | Use of n-acetyl-d-aminoglycosamine in preparation of drugs for the treatment of cacer and metastasis | |
AU2003295713A8 (en) | Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions |